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Background/aim: To determine the phenolic acid levels and DNA damage protection potential of Capparis spinosa L. seed extract and
to investigate the effect of the extract on cognitive impairment and oxidative stress in an Alzheimer disease mice model.
Materials and methods: Thirty BALB/c mice divided into 5 groups (control, D-galactose, D-galactose + C. spinosa 50, D-galactose + C.
spinosa 100, D-galactose + C. spinosa 200) were used. Mice were administered an injection of D-galactose (100 mg/kg, subcutaneous)
and orally administered C. spinosa (50, 100, or 200 mg/kg) daily for 8 weeks.
Results: Syringic acid was detected and the total amount was 204.629 µg/g. Addition of 0.05 mg/mL C. spinosa extract provided
significant protection against the damage of DNA bands. C. spinosa attenuated D-galactose-induced learning dysfunctions in mice
and significantly increased memory retention. Malondialdehyde (MDA) levels increased and superoxide dismutase (SOD), glutathione
peroxidase (GPx), and catalase (CAT) activities decreased in the D-galactose group. C. spinosa (200 mg/kg body weight) significantly
decreased MDA level and increased SOD, GPx, and CAT activities.
Conclusion: These results show that C. spinosa has the potential in ameliorating cognitive deficits induced by D-galactose in mice and
the antioxidant activity may partially account for the improvement of learning and memory function.
Key words: Alzheimer disease, Capparis spinosa L., D-galactose, oxidative stress, cognitive impairment

1. Introduction
Alzheimer disease (AD) is neurodegenerative disease,
characterized by the gradual deterioration of memory
and other cognitive functions. Increase in age is a major
risk factor for this disease and the prevalence of AD has
increased worldwide as the elderly population of the
world is increasing (1). The neuropathological hallmarks
of AD brains are amyloid beta fibrils in senile plaques,
neurofibrillary tangles, and neuronal loss (2). The
etiopathogenesis of AD is multifactorial and it is suggested
that oxidative stress has a significant role in the beginning
and progression of this disease, yet the sources of free
radicals and the mechanisms disrupting the redox balance
remain elusive (3–5).
D-Galactose is a reducing sugar found in the body.
When it is present at higher levels than normal, it can be
converted to galactitol by galactose oxidase, resulting in
the generation of oxygen-derived free radicals (6). Chronic
systemic exposure to D-galactose induces aging-related
* Correspondence: nergizht@yahoo.com

changes such as corruption of spatial learning, memory
loss, neurodegeneration, and diminishing activities of
antioxidant enzymes and increased production of free
radicals (7–9).
Capparis spinosa L. is a long-lasting shrubby plant
that belongs to the family Capparidaceae and grows
naturally throughout the world, especially widely in the
Mediterranean basin. It has been used since ancient times
for aromatic properties in cooking, and besides its use as
flavoring, C. spinosa has also been used as a traditional
herbal medicine for its antihypertensive, poultice, tonic,
and diuretic characteristics (10). This plant has been
investigated for several pharmacological effects. The bud
extract of C. spinosa inhibits the replication of herpes
simplex virus type 2 and upregulates the expression of
proinflammatory cytokines (11). It was demonstrated that
the methanol extracts of C. spinosa flowering buds have
antiallergic effectiveness (12), and the lyophilized extract
of C. spinosa buds shows in vitro antioxidant effectiveness
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in various models (13,14). Recently it was shown that C.
spinosa fruit extract may be a safe antihyperglycemic agent
for type 2 diabetic patients (15). It was demonstrated that
the aqueous extract of C. spinosa has potent lipid-lowering
activity in hyperglycemic rats (16). Other activities are
chondrocyte protective activity (17) and a protective
effect against oxidative stress in systemic sclerosis dermal
fibroblasts (18).
Previous studies for C. spinosa have reported
flavonoids, alkaloids, lipids, polyphenols, indole, and
glucosinolates (10,19). However, there are only few reports
on the seeds of C. spinosa. Seed oils of Capparis ovata and
C. spinosa from different parts of Turkey were analyzed,
showing the composition of fatty acids, tocopherols, and
sterols and the content of glucosinolates (20). Lam et al.
isolated and characterized a protein from C. spinosa seeds
with mitogenic activity, potent HIV-1 reverse transcriptase
activity, antifungal activity, and antiproliferative activity
(21). Recently, Duman and Ozcan reported the seed and
seed oil contents of C. spinosa species growing in Turkey
(22), and in another study they showed the phenolic matter
content and radical activity values of seeds of Capparis
species in Turkey (10). In that study high radical activity
was found for seeds of C. spinosa (10).
To the best of our knowledge there has been no study
that has investigated the effect of C. spinosa on cognitive
impairment. Therefore, in light of these considerations,
the current study was undertaken to investigate the effect
of C. spinosa in oxidative stress and cognitive impairment
in an AD mice model.
2. Materials and methods
2.1. Drug and chemicals
D-Galactose and the agents used for diagnostic purposes
were obtained from Sigma Chemical Co. (St. Louis, MO,
USA). Commercial kits used for the determination of
superoxide dismutase (SOD), glutathione peroxidase
(GPx), and catalase (CAT) were purchased from Cayman
Chemical Company (Ann Arbor, MI, USA). The purity of
all chemical reagents was of at least analytical grade.
2.2. Plant material and sample preparation
The seeds of C. spinosa were collected from the southeastern
region of Turkey (Gaziantep) in June 2013. Plant material
was authenticated by Assistant Professor Erol Dönmez, a
member of the Cumhuriyet University Faculty of Science’s
Department of Biology. After collection, the plant
material was dried by removing the water content in an
environment with no direct sunlight and good air flow. It
was then ground to a powder with the help of a blender.
The air-dried and finely ground samples were extracted
by using a method described elsewhere (23). Brieﬂy, the
sample, weighing about 100 g, was extracted in a Soxhlet
apparatus with methanol (MeOH) at 60 °C for 6 h. Due
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to the aqueous polar characteristics of the phenolic acids,
the extract was further fractionated with chloroform and
distilled water. Finally, the extracts were then lyophilized
and kept in the dark at 4 °C until tested.
2.3. Determination of phenolic acid levels of extracts
The analysis of phenolic acids was employed according
to the method described by Öztürk et al. (24) with a
slight modification using an Agilent HPLC series 1200
(Agilent, Waldbronn, Germany). The separation of gallic,
protocatechuic, p-hydroxy benzoic, vanillic, caffeic,
chlorogenic, syringic, p-coumaric, ferulic, o-coumaric,
rosmarinic, and trans-cinnamic acids was performed
on an Agilent Zorbax Eclipse XDB-C18 column (150
mm, 4.6 mm i.d., 5 µm particle size) (Figure 1). The
chromatographic conditions were: flow rate of 1 mL/min,
sample injection volume of 5 µL, operation temperature
of 23 °C, UV detection at 280 nm, and mobile phases A
(methanol : water : formic acid (10 : 88 : 2, v/v)) and B
(methanol : water : formic acid (90 : 8 : 2, v/v)). A gradient
program was used as follows: 100% A, 0–20 min; changed
to 80% A, 25–50 min, then to 50% A, 50–54 min; followed
by isocratic elutions of 50% A, 54–64 min, 0% A, and
64–70 min, 100% A. The results were evaluated with
regard to the areas of the peaks and their retention times.
Quantitation was based on calibration curves built for
each of the compounds identified in the samples.
2.4. Determination of DNA damage protection potential
of extracts
DNA damage protection activity of the extract was
evaluated on pBR322 plasmid DNA (Vivantis, Subang
Jaya, Malaysia). Plasmid DNA was oxidized with H2O2
+ UV treatment in the presence of extracts and checked
on 1% agarose gels according to Russo et al. after some
modifications (25). In brief, the experiments were
performed in a volume of 10 µL in a microfuge tube
containing 3 µL of pBR322 plasmid DNA (172 ng/µL), 1
µL of 30% H2O2, and 5 µL of extract in the concentrations
of 5, 10, 20, 40, and 50 µg/mL, respectively. The reactions
were initiated by UV irradiation and continued for 5 min
on the surface of a UV transilluminator (DNR-IS) with an
intensity of 8000 µW/cm2 at 302 nm at room temperature.
After irradiation, the reaction mixture (10 µL) along with
gel loading dye (6X) was loaded on a 1% agarose gel for
electrophoresis. Untreated pBR322 plasmid DNA was
used as a control in each run of gel electrophoresis along
with partially treated plasmid, i.e. only UV or only H2O2
treatment. Gels were stained with EtBr and photographed
with the gel documentation system (MiniBIS Pro, DNR-IS,
Jerusalem, Israel).
2.5. Animals and drug administration
Male 8-week-old BALB/c mice (n = 30) were used. All
experiments were conducted at Cumhuriyet University. Six
mice were housed per cage under standardized conditions
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(12-h light/dark cycle, 24 ± 2 °C, 35% to 60% humidity)
and allowed a commercial standard mice diet and water ad
libitum. The experiments were performed in accordance
with the Guide for the Care and Use of Laboratory
Animals. The study protocol was approved by the Animal
Ethics Committee of Cumhuriyet University (Turkey).
After 1 week of adaptation the mice were randomly
divided into 5 groups (n = 6 in each group): control,
D-galactose, D-galactose + C. spinosa 50, D-galactose + C.
spinosa 100, and D-galactose + C. spinosa 200. D-galactose
was dissolved in sterile saline (0.3 mL) and injected
subcutaneously (100 mg/kg daily) for 60 continuous days
(26,27) while mice in the control group were treated with
the same volume of sterile saline. D-galactose + C. spinosa
mice were orally administered lyophilized C. spinosa
extract at the doses of 50, 100, and 200 mg/kg per day
respectively after subcutaneous injection of D-galactose
(100 mg/kg daily). At the end of the drug administration
period, behavioral tests and biochemical analysis were
performed. During the entire experimental process the
mice were weighed each week.
2.6. Morris water maze
The Morris water maze test was performed according to
the methods described previously (28). The procedure of
this test consisted of 2 learning and memory training trials
per day for 4 consecutive days and after that a probe trial
was performed on day 5 for each mouse. The experimental
apparatus consisted of a circular pool 150 cm in diameter
and 35 cm deep, filled with water kept at 24 ± 1 °C. The
pool was divided into 4 quadrants of equal areas. A
platform (4.5 cm in diameter) was placed 1 cm below the
water surface at the midpoint of 1 quadrant.
2.6.1. Spatial navigation task
In each daily trial, a mouse was placed in the water maze
at a determined location and the animal was allowed to
find the hidden platform. The time needed for each mouse
to find the hidden platform was recorded for all trials. A
mouse that found the platform was allowed to stay on the
platform for 15 s to memorize its location and was then
returned to its cage for an interval. If it failed to find the
platform within 60 s, escape latency was recorded as 60
s. Latency to escape (finding the hidden platform) was
recorded in each trial. The extent of learning was assessed
with this test.
2.6.2. Probe test
The spatial probe test was performed on day 5 by removing
the platform. Each mouse was allowed to swim for 60
s. The time required for the mouse to reach the target
quadrant, the time that mouse spent swimming in the
target quadrant, and the number of crossings over the
platform zone were recorded. Memory consolidation was
assessed with this test.

2.7. Biochemical analysis
Mice were sacrificed 24 h after Morris water maze test. The
whole brain tissue was excised immediately in ice-cold
conditions, blotted free of blood and tissue fluids, weighed,
and stored at –80 °C for further analysis.
2.7.1. Estimation of lipid peroxidation
Lipid peroxidation was monitored in terms of
malondialdehyde (MDA) by the method of Ohkawa et al.
(29). MDA level was determined by thiobarbituric acid
reactive substances (TBARS) in brain tissue homogenate,
based on the reaction between MDA and thiobarbituric
acid. Thiobarbituric acid when allowed to react with MDA
aerobically formed a colored complex [MDA-(TBA) 2
complex], which was measured by spectrophotometer
(Shimadzu UV-1700, Shimadzu, Kyoto, Japan) at 532 nm.
MDA concentration (measured as TBARS) was calculated
as nmol/mL. Absorbance values were compared with a
series of standard solutions of 1,1,3,3-tetraethoxypropane.
2.7.2. Measurement of SOD activity
SOD was determined by using a commercially available
standard enzymatic kit (Cayman Chemical Company)
and following the manufacturer’s instructions. Brain tissue
was homogenized in cold 20 mM HEPES buffer (pH 7.2)
containing 1 mM EGTA, 210 mM mannitol, and 70 mM
sucrose per gram of tissue and was centrifuged at 1500 × g
for 5 min at 4 °C. The supernatant was removed and stored
on ice for total SOD activity (cytosolic and mitochondrial)
assay according to the protocol provided by the assay kit
manufacturer. The absorbance was read at 440–460 nm
using a plate reader. The SOD activity was expressed as
U/mg protein. This kit utilizes a tetrazolium salt for the
detection of superoxide radicals generated by xanthine
oxidase and hypoxanthine. The SOD assay measures all 3
types of SOD (CU/Zn, Mn, and Fe SOD). One unit of SOD
is defined as the amount of enzyme needed to exhibit 50%
dismutation of the superoxide radical.
2.7.3. Measurement of GPx activity
GPx activity was measured using a commercially available
kit (Cayman Chemical Company) and following the
manufacturer’s instructions. Brain tissue was homogenized
in 50 mM Tris-HCl buffer (pH 7.5), containing 5 mM
EDTA and 1 mM DTT per gram of tissue and centrifuged at
10,000 × g for 15 min at 4 °C to obtain supernatant for GPx
analysis. The removed supernatant was stored on ice and
the absorbance was read once every minute at 340 nm using
a plate reader to obtain at least 5 time points. Levels of GPx
activity were expressed as nmol min–1 mg protein–1 in tissue.
The measurement of GPx activity is based on the principle
of a coupled reaction with glutathione reductase (GR). The
oxidized glutathione (GSSG) formed after the reduction of
hydroperoxide by GPx is recycled to its reduced state by GR
in the presence of NADPH accompanied by a decrease in
absorbance at 340 nm. One unit of GPx is defined as the
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amount of enzyme that catalyzes the oxidation of 1 nmol of
NADPH per minute at 25 °C.
2.7.4. Measurement of CAT activity
CAT activity was measured using a commercially available
kit (Cayman Chemical Company) and following the
manufacturer’s instructions. Brain tissue was homogenized
in 50 mM potassium phosphate (pH 7.0), containing 1 mM
EDTA per gram of tissue and centrifuged at 10,000 × g for
15 min at 4 °C to obtain supernatant for CAT analysis. The
removed supernatant was stored on ice and the absorbance
was read at 540 nm. Levels of CAT activity were expressed
as nmol min–1 mg protein–1 in tissue. The measurement of
CAT activity is based on the reaction of the enzyme with
methanol in the presence of an optimal concentration
of H2O2. The formaldehyde produced is measured
colorimetrically with 4-amino-3-hydrazino-5-mercapto1,2,4-triazole (Purpald) as the chromogen. Purpald forms
a bicyclic heterocycle with aldehydes that after oxidation
changes from colorless to purple. One unit of CAT is defined
as the amount of enzyme that will cause the formation of 1.0
nmol of formaldehyde per minute at 25 °C.
2.7.5. Protein assay
The total protein content was estimated by the method
of Bradford (30). Bovine serum albumin was used as the
standard.
2.8. Statistical analyses
Data were analyzed using the SPSS 15 for Windows (SPSS
Inc., Chicago, IL, USA). The results were expressed as
means ± standard deviation (SD). The data obtained from
the spatial navigation task were analyzed using 2-way
ANOVA followed by Tukey–Kramer multiple comparison
tests as a post hoc test with repeated measures and the
factors were groups and training days. The other data were
analyzed with 1-way ANOVA followed by Newman–Keuls

or Tukey–Kramer multiple comparison tests as the post
hoc test. P < 0.05 was regarded as significant.
3. Results
3.1. Phenolic acid levels of extracts
In this study, amounts of gallic, protocatechuic,
p-hydroxybenzoic, vanillic, caffeic, chlorogenic, syringic,
p-coumaric, ferulic, o-coumaric, rosmarinic, and transcinnamic acids were quantified in polar methanol extracts
of C. spinosa. Due to the polar characteristics of phenolic
acids, as mentioned in Section 2, methanol extracts
obtained from the plants were also further fractionated
with equal amounts of chloroform and distilled water. In
this way, nonpolar phytochemicals were eliminated from
the target extract. Polar phytochemicals brought together
within the water fraction were lyophilized and stored at
4 °C until tested and analyzed. In C. spinosa extract, only
syringic acid was detected, and the total amount was
204.629 µg/g (Figure 1).
3.2. DNA damage protection potential of extracts
Figure 2 shows the electrophoretic pattern of DNA after
UV photolysis of H2O2 in the absence and presence of the
aqueous extract of C. spinosa. DNA derived from pBR322
plasmid showed 2 bands upon agarose gel electrophoresis
(column 1); the faster moving band corresponded to the
native form of supercoiled circular DNA (scDNA) and the
slower moving band was the open circular form (ocDNA).
The UV irradiation of DNA in the presence of H2O2
(column 3) resulted in the cleavage of ocDNA to a faint
linear DNA and smears on the agarose gel, indicating that
the OH· generated from UV photolysis of H2O2 produced
DNA strand scission.
As can be seen from the Figure 2, columns 6–9 show the
DNA damage protection potential of the aqueous extract of

Figure 1. HPLC chromatogram showing phenolic acids available in C. spinosa [1: Syringic acid, Rt (minutes):
18.074, source of confirmation: UV, IS: internal standard, Rt (minutes): 53.833].
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Data 1

Escape latency (s)

80

Figure 2. Electrophoretic pattern of pBR322 plasmid DNA
after treatment with UV and H2O2 in the presence of C. spinosa
aqueous extract. Column 1: Plasmid DNA (3 µL) + dH2O (6 µL),
Column 2: plasmid DNA (3 µL) + dH2O (6 µL) + UV, Column 3:
plasmid DNA (3 µL) + dH2O (6 µL) + UV + H2O2 (1 µL), Column
4: plasmid DNA (3 µL) + dH2O (6 µL) + H2O2 (1 µL), Column
5: plasmid DNA (3 µL) + aqueous extract (0.005 mg/mL, 5 µL)
+ UV + H2O2 (1 µL), Column 6: plasmid DNA (3 µL) + aqueous
extract (0.01 mg/mL, 5 µL) + UV + H2O2 (1 µL), Column 7:
plasmid DNA (3 µL) + aqueous extract (0.02 mg/mL, 5 µL) + UV
+ H2O2 (1 µL), Column 8: plasmid DNA (3 µL) + aqueous extract
(0.04 mg/mL, 5 µL) + UV + H2O2 (1 µL), Column 9: plasmid
DNA (3 µL) + aqueous extract (0.05 mg/mL, 5 µL) + UV + H2O2
(1 µL).

C. spinosa. In columns 6, 7, and 8, 2 major bands labeled as
ocDNA and scDNA are protected by the presence of 0.01,
0.02, and 0.04 mg/mL extract concentration, respectively.
The addition of 0.05 mg/mL C. spinosa extract to the
reaction mixture conferred significant protection against
damage of all DNA bands (column 9), while the addition
of lowest extract concentration (0.005 mg/mL) did not
show any protection against DNA damage (column 5).
3.3. Effect of C. spinosa on learning and memory
performance
3.3.1. Spatial navigation task
To investigate the effect of C. spinosa on D-galactoseinduced cognitive impairment, we used the Morris water
maze test. This test is a sensitive test for determining the
impairment of spatial learning and memory (26). Two-way
repeated measures ANOVA (day × group) showed that
there was a significant difference in mean latency between
groups (F = 33.76, P = 0.001, P < 0.01) and also that there
was a significant difference in mean latency between days
(F = 48.68, P = 0.001, P < 0.01). The D-galactose mice spent
a longer time finding the platform than control group mice
on training days (day 1, P > 0.05; day 2, P < 0.01; day 3, P
< 0.01; day 4, P < 0.01). This showed that D-galactose mice
had significant cognitive impairment. On the other hand,
mice treated daily with C. spinosa at 200 mg/kg decreased
the time for escape latency significantly when compared to
D-galactose mice from the second day onwards (P < 0.01,
P < 0.01, and P < 0.01). C. spinosa treatment at 50 mg/kg
and 100 mg/kg daily had similar effects (P < 0.05, P < 0.05,
and P < 0.05) (Figure 3). These results show that both day
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Figure 3. Effect of C. spinosa on the escape latency of D-galactosetreated mice in Morris water maze test. Escape latencies to
find a hidden platform in the water maze were measured over
4 consecutive days of training. D-galactose was dissolved in
sterile saline (0.3 mL) and injected subcutaneously (100 mg/
kg daily) for 60 continuous days and control group mice were
treated with the same volume of sterile saline. D-galactose + C.
spinosa groups were orally administered lyophilized C. spinosa
extract at the doses of 50, 100, or 200 mg/kg per day respectively
after subcutaneous injection of D-galactose (100 mg/kg daily).
Data are expressed as mean ± SD (n = 6 in each group). ##: P <
0.01 compared with control group; **: P < 0.01 and *: P < 0.05
compared to D-galactose group.

and group had significant effect on the escape latency and
all groups of rats improved over the training trials. There
was a significant interaction between day and group factors
in escape latency. These results indicate that C. spinosa in
a dose-dependent manner prevented D-galactose-induced
learning dysfunction in mice.
3.3.2. Probe test
On day 5, data were obtained from 3 measurements of
probe test performance. In the probe test, for mice in the
control and the 100 and 200 mg/kg C. spinosa groups, the
time spent to find the target quadrant was shorter than in
the D-galactose group (P < 0.01 versus control group; P <
0.01 versus C. spinosa 100 group; P < 0.01 versus C. spinosa
200 group) (Figure 4A). Mice in the control and C. spinosa
200 groups spent a longer time swimming in the target
quadrant than the mice in the D-galactose group (P < 0.01
versus control group; P < 0.01 versus C. spinosa 200 group)
(Figure 4B). Similar results were obtained for the number
of times the mice crossed the platform location. Mice
treated with D-galactose crossed the platform location
less frequently than mice in the control (P < 0.01) and C.
spinosa 100 (P < 0.05) and 200 (P < 0.01) groups (Figure
4C). These results indicated that C. spinosa treatment at a
daily dose of 200 mg/kg significantly increased memory
retention compared to D-galactose-treated mice.
3.4. Effect of C. spinosa on MDA contents in the brain
and SOD, GPx, and CAT activities
MDA levels, a main index of lipid peroxidation, were
significantly increased in mice given D-galactose
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Figure 4. Effect of C. spinosa on behavior of D-galactose (D-gal)-treated mice in Morris water maze test. D-galactose
was dissolved in sterile saline (0.3 mL) and injected subcutaneously (100 mg/kg daily) for 60 continuous days
and control group mice were treated with the same volume of sterile saline. D-galactose + C. spinosa groups were
orally administered lyophilized C. spinosa extract at the doses of 50, 100, or 200 mg/kg per day respectively after
subcutaneous injection of D-galactose (100 mg/kg daily). Data are expressed as mean ± SD (n = 6 in each group).
(A) Comparison of the time required to reach the target quadrant on day 5, (B) comparison of the time spent in the
target quadrant on day 5, (C) comparison of number of times crossing over the platform site on day 6. ##: P < 0.01
compared with control group; **: P < 0.01 and *: P < 0.05 compared to D-galactose group.

compared to the control group (P < 0.05). Treating mice
with C. spinosa depressed MDA enhancement in brains of
D-galactose-treated mice and the effect of C. spinosa was
dose-dependent (P < 0.01 or P < 0.05) (Figure 5).
A significant decrease (P < 0.05) in the levels of SOD,
GPx, and CAT were noticed in D-galactose mice when
compared to control mice. Administration of C. spinosa
dose-dependently prevented the D-galactose-induced
decrease in brain SOD and GPx and CAT activities. C.
spinosa showed the strongest effect at improving the SOD,
GPx, and CAT activities in the brain at a dose of 200 mg/
kg per day (Figure 6).
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4. Discussion
AD is a neurodegenerative disease that causes dementia;
after diagnosis, it leads to a complete incapacity and
death within 3 to 9 years. For preventing or retarding the
disease process there is a need to develop new agents as
current therapies against AD have limited effectiveness.
The exact cause and pathogenesis of AD is not completely
understood. It is accepted that oxidative stress plays a key
role in many aging-related diseases such as Parkinson
disease and AD (31). A lipid peroxidation product, MDA
is increased in cerebrospinal fluid and brain regions of
patients with AD (32,33), and reduction of antioxidant
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Figure 5. Effect of C. spinosa on the level of MDA in brain tissue
of D-galactose (D-gal)-treated mice. D-galactose was dissolved
in sterile saline (0.3 mL) and injected subcutaneously (100 mg/
kg daily) for 60 continuous days and control group mice were
treated with the same volume of sterile saline. D-galactose + C.
spinosa groups were orally administered lyophilized C. spinosa
extract at the doses of 50, 100, or 200 mg/kg per day respectively
after subcutaneous injection of D-galactose (100 mg/kg daily).
Data are expressed as mean ± SD (n = 6 in each group). ##: P
< 0.01 compared with control group; **: P < 0.01 compared to
D-galactose group.

enzymes such as GPx and SOD have been seen in
central nervous system of AD patients (34). It has been
demonstrated that in AD oxidative stress is linked with
several pathological processes such as mitochondria
dysfunction, amyloid beta-induced neurotoxicity,
metal dyshomeostasis, and tau pathology (1). Because
of this, using natural antioxidants that are capable of
targeting different molecular events that are involved in
the pathogenesis of AD may be a good approach in the
prevention or treatment of this disease.
The present study was done to examine the effect of
C. spinosa seed extracts on cognitive impairment induced
by D-galactose in mice. To the best of our knowledge, this
study shows for the first time that C. spinosa seed extracts
have potential in ameliorating cognitive deficits induced
by D-galactose in mice by inhibiting oxidative stress in a
dose-dependent manner.
Mainly because of their redox properties, phenolic
compounds have antioxidant activity. This activity allows
them to reduce free radicals and metal chelators; thus, they
prevent many diseases including myocardial infarction,
atherosclerosis, and cancer (35–37). In this study, gallic,
protocatechuic, p-hydroxybenzoic, vanillic, caffeic,
chlorogenic, syringic, p-coumaric, ferulic, o-coumaric,

rosmarinic, and trans-cinnamic acids were investigated in
polar methanol extracts of C. spinosa and syringic acid was
detected at a total amount of 204.629 µg/g. Syringic acid is
a natural phenolic acid with a strong antioxidant effect that
has multiple pharmacological properties such as anticancer
effects and antihypertensive and hepatoprotective effects
(38–40). DNA damage protection potential of extracts was
also determined. The lowest extract concentration (0.005
mg/mL) showed no protection against DNA damage.
In the presence of 0.01, 0.02, and 0.04 mg/mL extract
concentration, 2 major bands, named ocDNA and scDNA,
were protected while the application of 0.05 mg/mL C.
spinosa extract showed significant protection against the
damage of all DNA bands. These results show that C.
spinosa extract has DNA damage protection potential at a
significant level.
D-Galactose injection is used to induce the mimicking
of some characters of cognitive dysfunction and oxidative
damage in experimental animals that look like accelerated
aging. In order to explain the mechanism of D-galactose,
many hypotheses have been put forward; one of them is
that chronic systemic exposure to D-galactose increases
levels of MDA and lipofuscin and also decreases GPx
and SOD activities (6,41). In our study, when the Morris
water maze test was applied, we observed that long-term
administration of D-galactose in mice caused cognitive
deficit and showed significant impairment of learning
and memory ability. This finding is consistent with other
studies that reported cognitive impairment by D-galactose
in rodents (8,26,41). Morris water maze tests suggested
that C. spinosa attenuated D-galactose-induced cognitive
impairment as detected by diminishing latency to reach
the hidden platform. We also observed that C. spinosa
significantly increased the time spent in the target
quadrant and the number of times that mice crossed the
platform location. These results indicate that C. spinosa in
a dose-dependent manner prevented D-galactose-induced
learning dysfunction in mice and also increased memory
retention compared to D-galactose-treated mice.
Many experimental and human studies indicate that in
the development and progression of AD oxidative stress is
one of the important factors (1,42,43). Free radicals take
part in neuronal degeneration and accelerating aging. In
order to protect cells against oxidative damage induced
by free radicals, endogenous antioxidant enzymes such as
CAT, SOD, and GPx are activated in the body. As there is
a strong correlation between oxidative stress and cognitive
dysfunction, these antioxidant enzymes have important
roles in fixing memory and learning deficits (7,8). In
our study, decreased levels of SOD, GPx, and CAT were
observed in D-galactose-treated mice. However, C. spinosa
significantly increased the activities of SOD, GPx, and CAT,
showing that C. spinosa improved antioxidant activity. The
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Figure 6. Effect of C. spinosa on the activity of SOD, GPx, and CAT in brain tissue of D-galactose (D-gal)-treated mice.
D-galactose was dissolved in sterile saline (0.3 mL) and injected subcutaneously (100 mg/kg daily) for 60 continuous
days and control group mice were treated with the same volume of sterile saline. D-galactose + C. spinosa groups
were orally administered lyophilized C. spinosa extract at the doses of 50, 100, or 200 mg/kg per day respectively after
subcutaneous injection of D-galactose (100 mg/kg daily). Data are expressed as mean ± SD (n = 6 in each group). ##: P
< 0.01 compared with control group; **: P < 0.01 and *: P < 0.05 compared to D-galactose group.

enhanced activities of these antioxidant enzymes could
be effective in eliminating different types of oxygen free
radicals and their products, reversing D-galactose-induced
cognitive deficits produced by oxidative damage.
Under conditions of oxidative stress MDA is an
important indicator of membrane damage. Again in
agreement with previous reports in brain tissue of mice
treated with D-galactose, there was a significant increase
in MDA levels, a product of lipid peroxidation (41,42).
C. spinosa significantly decreased the level of MDA,
showing that C. spinosa could decrease the production
of MDA induced by D-galactose, and it improved the
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oxidative stress in the brain induced by D-galactose. The
increased activities of SOD, GPx, and CAT and free radical
scavenging activity in mice fed C. spinosa could contribute
to its inhibitory effect on lipid peroxidation. The reduction
of oxidative stress in the brain may be one mechanism
by which C. spinosa improved learning and memory
functions in D-galactose-treated rats.
In conclusion, our study demonstrated that C. spinosa
significantly improved cognitive impairment induced
by D-galactose injection in mice in a dose-dependent
manner. We think that the syringic acid, a natural phenolic
acid with a strong antioxidant ability detected in the C.

TURGUT et al. / Turk J Med Sci
spinosa seed extracts, has an important role in this effect
and this effect may be mediated partly through regulating
the activities of antioxidant enzymes and scavenging
free radicals. The effect of C. spinosa is likely through
attenuating oxidative stress as demonstrated by increasing
activities of SOD, GPx, and CAT enzymes and decreasing
levels of MDA. These results suggest that C. spinosa may
be a useful additive in addition to the current treatment

of AD patients. Additional research with more detailed
work is necessary to completely understand the molecular
mechanisms behind the positive effect of C. spinosa against
D-galactose-induced cognitive impairment.
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